Who Can Legally Give Injectable Treatments in London?

In England, botulinum toxin injections for cosmetic use require a prescription for the individual, issued after an appropriate clinical assessment by a qualified prescriber. A trained non-prescribing injector may administer a medicine that has been prescribed, but cannot make the prescribing decision. Dermal fillers are regulated differently and are not prescription-only medicines.

What is the legal difference between anti-wrinkle injections and dermal fillers?

The crucial distinction is the product category. Botulinum toxin medicines used in cosmetic anti-wrinkle injections are prescription-only medicines. A prescriber must decide that the medicine is appropriate for a particular person and issue a prescription before it can be supplied and used. This is not simply an administrative step: prescribing carries clinical and professional responsibility.

That means the person giving an anti-wrinkle injection and the person prescribing it may be the same clinician, but they do not have to be. Where they are different people, the injector needs to work from a valid prescription and within their own training, competence and professional remit. The injector cannot substitute their own view for the prescriber’s decision about whether that prescription-only medicine is suitable.

Dermal fillers have a different legal position. They are generally regulated as medical devices rather than prescription-only medicines, so a prescription is not required in the same way. This does not make filler treatment risk-free, nor does it show that a practitioner has the necessary knowledge of facial anatomy, complications, consent or emergency response. It means only that the prescription requirement which applies to botulinum toxin medicines does not apply to fillers.

At a consultation, ask which product category is being discussed and who is clinically responsible for each stage. This matters where a practice offers both treatments, because the route by which the product is obtained and the responsibilities of the people involved may differ. The treatment name used in advertising is not enough to establish the underlying legal position.

Why must the prescriber assess the patient personally?

A prescription is a decision about an individual, not a product order for a clinic. Before prescribing, the clinician must have enough information to judge whether the medicine serves that person’s needs and can be used safely. In aesthetic practice, that normally includes understanding the treatment requested, relevant medical history, current medicines, allergies where relevant, previous treatment, expectations, and whether there are reasons to defer or decline treatment.

The General Medical Council’s guidance on cosmetic interventions states that doctors must carry out the assessment of a patient themselves and must not delegate that responsibility. Its prescribing guidance also requires doctors to have adequate knowledge of a patient’s health and to be satisfied that medicines serve the patient’s needs. These principles explain why an injector’s description of a prospective patient is not an equivalent replacement for the prescriber’s own assessment.

The assessment also helps establish who can answer questions about the medicine, alternatives, expected effects and material risks. It creates a clear clinical chain of responsibility if the treatment plan changes or a complication occurs. It should happen before the prescription decision, rather than being treated as a retrospective signature.

An assessment is distinct from a sales conversation or a form completed in advance. Forms and photographs may provide useful background, but the prescriber remains responsible for deciding whether the information is sufficient and for addressing matters that need further exploration. Patients should be able to identify the clinician making that decision and understand how to contact them with relevant questions before treatment.

Which professionals can prescribe, and which register should you check?

In England, prescribing rights depend on a professional’s registration, qualification, annotation where applicable, and scope of practice. Doctors and dentists may prescribe within their competence. Some registered nurses, pharmacists, optometrists, physiotherapists and podiatrists can qualify as independent prescribers. The fact that someone belongs to one of those professions does not by itself establish that they hold the relevant prescribing qualification or that a particular cosmetic prescription is within their competence.

A non-prescribing nurse, dental professional or other trained practitioner may be able to administer a prescription-only medicine after it has been prescribed for the patient, provided they work within their competence and applicable professional standards. They do not gain prescribing authority through injection training alone. Conversely, a prescriber should not prescribe outside the limits of their knowledge, skills and experience merely because another practitioner will perform the injection.

Search using the practitioner’s full name and registration number where available. A register check is a starting point, not proof that every proposed treatment is appropriate. It can also help distinguish a regulated professional title from a description used in marketing. If the stated role and the register entry do not appear to match, seek clarification before making an appointment.

Can a prescription be issued after a remote consultation?

Remote prescribing means that the prescriber decides whether to prescribe without meeting the patient face to face. The law does not create one simple rule that makes every remote prescription unlawful. The question is whether the prescriber can conduct an adequate assessment, meet the standards of their regulator, and safely take responsibility for the decision in the circumstances.

For cosmetic injectable medicines, professional standards have raised particular concerns about prescribing solely through messages, photographs, a form or a brief video call. Such methods may limit the prescriber’s ability to assess the person, explore relevant history, identify pressure or unrealistic expectations, verify identity, and examine matters that require direct observation. A photograph cannot necessarily show what a clinical examination would reveal.

The Nursing and Midwifery Council has stated that remote prescribing for botulinum toxin and other prescription-only medicines for cosmetic procedures is not appropriate. The General Medical Council’s cosmetic-interventions guidance requires doctors to undertake the assessment themselves rather than delegate it. These are professional standards, not a substitute for individual clinical judgement, but they give patients a clear reason to ask how and when the prescriber assessed them.

A useful question is: Will the prescriber who makes the decision meet and assess me before prescribing, and can I speak with them directly? If the answer is unclear, pause before proceeding. It is also useful to ask whether the prescriber will be told about any relevant change between assessment and treatment. This is a question about process, not a diagnosis or treatment recommendation.

What can a non-prescribing injector do, and what can they not do?

A non-prescribing injector can have significant practical and clinical responsibilities. Depending on their profession, training and competence, they may consult with a patient, obtain consent within their role, administer a prescription-only medicine that has been prescribed for that individual, keep treatment records, provide aftercare information and recognise when escalation is needed. Their precise responsibilities depend on their professional status and the arrangements in place.

What they cannot do is make the prescription decision if they do not have prescribing rights. They cannot independently decide that a prescription-only medicine is appropriate, issue the prescription, or use a prescriber’s name as a routine route to obtain medicine without the prescriber conducting an adequate individual assessment. A prescriber remains responsible for their prescribing decision and should not be treated as a distant supplier.

This distinction is sometimes obscured by phrases such as medical-led or prescriber available. Those phrases do not explain whether a patient-specific assessment has occurred. Ask for names and roles: who will prescribe, who will inject, whether they are the same person, and how the two clinicians communicate if they are not.

It is also reasonable to ask what happens if the injector identifies new information on the day of treatment. A suitable process should allow the plan to be reconsidered rather than assume that a prior prescription settles every issue. The person administering an injection still has their own responsibility to work within competence and to respond appropriately where new information may affect treatment.

What should a London patient check before booking?

Checking credentials is a practical part of deciding whether to attend a consultation. Start with the specific treatment rather than a general description of the practice. If it involves a botulinum toxin medicine, identify the prescriber by name, confirm their professional register, and ask how they will assess you before prescribing. If another person will inject, ask for their name, profession, training relevant to the procedure and how they work with the prescriber.

For filler treatment, there may be no prescription step, so other safeguards take greater importance. Ask who will perform the treatment, what relevant anatomy and complication training they have, how consent is handled, what product information will be recorded, and what arrangements exist if a complication needs urgent clinical attention. Do not assume that the absence of a prescription requirement means that no clinical standard applies.

Decision rule to save: If the treatment uses a prescription-only medicine, do not book until you can name the prescriber, find them on the appropriate statutory register, and understand when they will assess you. If the treatment is filler, check the injector’s identity, register if they are a regulated professional, relevant competence, and complication arrangements.

Keep written confirmation of names and roles alongside your own consultation notes. Public registers can confirm registration, but they do not replace asking direct questions about the planned treatment. If information changes between consultation and appointment, ask for the change to be explained before consenting. A practitioner should be able to state their role without relying on general claims about the organisation.

What records and consent information should be clear?

Consent is an ongoing process rather than a form alone. Before an injectable procedure, a patient should have enough information to understand what is proposed, who will carry it out, the relevant risks, alternatives and aftercare. For prescription-only medicines, it should also be clear who assessed the patient and made the prescribing decision. If different people are involved, their separate roles should not be left ambiguous.

Records matter because they support continuity of care if questions arise later. It is reasonable to ask what treatment details will be recorded and whether the record identifies the product used, the practitioner who administered it, and the prescriber where relevant. A patient may also wish to know how they can obtain aftercare advice, including outside normal appointment times where a concern needs prompt attention.

For fillers, prompt recognition and management of complications can be important. This does not mean every concern has the same urgency, but patients should understand the route for seeking advice and whether there is a documented escalation arrangement. The appropriate response will depend on symptoms and the clinical circumstances. A practice should not present routine reassurance as a replacement for explaining what to do if a concerning change develops.

These questions are useful before treatment, when a patient can consider the answers without time pressure. They are not intended to transfer clinical responsibility to the patient. The regulated professional or practitioner remains responsible for their own work, including working within the limits of their competence.

Limits of this guide

This is a general England-focused regulatory reference for adults considering non-surgical cosmetic injectable treatment in London. It does not provide medical advice, decide whether any treatment is clinically suitable, or assess the competence of an individual practitioner. It does not cover surgical procedures, medicines prescribed for medical conditions, dental treatment, or the rules in Scotland, Wales, Northern Ireland or other countries.

Professional registration is not the same as specialist expertise in every aesthetic procedure. A register can establish whether a named professional is registered and, in some cases, whether a prescribing annotation is recorded. It cannot by itself confirm the quality of a consultation, the appropriateness of a proposed prescription, the provenance of a product, or the standard of aftercare.

Rules, professional guidance and local arrangements can change. Where a treatment is proposed, the relevant question is not whether a practice uses reassuring language, but whether the named people can explain their roles, their regulatory basis and the route for raising concerns. If a person claims to be a regulated professional, use the register of their stated regulator rather than relying on social-media profiles, testimonials or a title used in advertising.

This guide also does not replace information given during a consultation, including discussion of risks, alternatives, expected outcomes and aftercare. Those matters should be addressed in the context of the individual treatment plan.